The DOI matches its Crossref record; 66 of the 67 references it cites were found in a registry or an index.
Regulation of cancer cell metabolism by hypoxia-inducible factor 1
Abstract
The induction of hypoxia-inducible factor 1 (HIF-1) activity, either as a result of intratumoral hypoxia or loss-of-function mutations in the VHL gene, leads to a dramatic reprogramming of cancer cell metabolism involving increased glucose transport into the cell, increased conversion of glucose to pyruvate, and a concomitant decrease in mitochondrial metabolism and mitochondrial mass. Blocking these adaptive metabolic responses to hypoxia leads to cell death due to toxic levels of reactive oxygen species. Targeting HIF-1 or metabolic enzymes encoded by HIF-1 target genes may represent a novel therapeutic approach to cancer.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“HIF-1α also activates metabolic genes, such as PGK-1 and PFK1A, which increase glycolysis for ATP production during hypoxia (Semenza, 2009).”
From SirT3 suppresses hypoxia inducible factor 1α and tumor growth by inhibiting mitochondrial ROS production (2011) · cites this paper as Semenza, 2009
Citations
Cites
1 retracted
Mitochondrial Autophagy Is an HIF-1-dependent Adaptive Metabolic Response to Hypoxia
Zhang, H., Bosch-Marce, M., Shimoda, L. A., Tan, Y. S., Baek, J. H., Wesley, J. B., Gonzalez, F. J., & Semenza, G. L. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m800102200 · Cited by 1,601
Self-citationRetractedTargeting HIF-1 for cancer therapy
Semenza, G. L. (2003) · Nature Reviews Cancer · doi:10.1038/nrc1187 · Cited by 6,717
Self-citationWang, G. L., Jiang, B. H., Rue, E. A., & Semenza, G. L. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.12.5510 · Cited by 6,212
Self-citationJaakkola, P., Mole, D. R., Tian, Y.-M., Wilson, M. I., Gielbert, J., Gaskell, S. J., Kriegsheim, A. V., Hebestreit, H. F., Mukherji, M., Schofield, C. J., et al. (2001) · Science · doi:10.1126/science.1059796 · Cited by 5,535
The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis
Maxwell, P. H., Wiesener, M. S., Chang, G.-W., Clifford, S. C., Vaux, E. C., Cockman, M. E., Wykoff, C. C., Pugh, C. W., Maher, E. R., & Ratcliffe, P. J. (1999) · Nature · doi:10.1038/20459 · Cited by 5,180
HIFα Targeted for VHL-Mediated Destruction by Proline Hydroxylation: Implications for O 2 Sensing
Ivan, M., Kondo, K., Yang, H., Kim, W., Valiando, J., Ohh, M., Salic, A., Asara, J. M., Lane, W. S., & Kaelin Jr., W. G. (2001) · Science · doi:10.1126/science.1059817 · Cited by 4,735
Kim, J.-W., Tchernyshyov, I., Semenza, G. L., & Dang, C. V. (2006) · Cell Metabolism · doi:10.1016/j.cmet.2006.02.002 · Cited by 3,905
Self-citationEpstein, A. C. R., Gleadle, J. M., McNeill, L. A., Hewitson, K. S., O'Rourke, J., Mole, D. R., Mukherji, M., Metzen, E., Wilson, M. I., Dhanda, A., et al. (2001) · Cell · doi:10.1016/s0092-8674(01)00507-4 · Cited by 3,333
Discovery and development of bevacizumab, an anti-VEGF antibody for treating cancer
Ferrara, N., Hillan, K. J., Gerber, H.-P., & Novotny, W. (2004) · Nature Reviews Drug Discovery · doi:10.1038/nrd1381 · Cited by 2,625
Cellular and developmental control of O 2 homeostasis by hypoxia-inducible factor 1α
Iyer, N. V., Kotch, L. E., Agani, F., Leung, S. W., Laughner, E., Wenger, R. H., Gassmann, M., Gearhart, J. D., Lawler, A. M., Yu, A. Y., et al. (1998) · Genes & Development · doi:10.1101/gad.12.2.149 · Cited by 2,476
Self-citation
Cited by
Sorted by citations
Items 101–200 of 475
The role of HIF1α in renal cell carcinoma tumorigenesis
Gudas, L. J., Fu, L., Minton, D. R., Mongan, N. P., & Nanus, D. M. (2014) · Journal of Molecular Medicine · doi:10.1007/s00109-014-1180-z · Cited by 106
Hashimoto, O., Shimizu, K., Semba, S., Chiba, S., Ku, Y., Yokozaki, H., & Hori, Y. (2011) · Pathobiology · doi:10.1159/000325538 · Cited by 108
The anti-oxidant capacity of tumour glycolysis
Sattler, U. G. A., & Mueller‐Klieser, W. (2009) · International Journal of Radiation Biology · doi:10.3109/09553000903258889 · Cited by 106
Fardin, P., Barla, A., Mosci, S., Rosasco, L., Verri, A., Versteeg, R., Caron, H. N., Molenaar, J. J., Øra, I., Eva, A., et al. (2010) · Molecular Cancer · doi:10.1186/1476-4598-9-185 · Cited by 102
Clinical Applications and Anticancer Effects of Antimicrobial Peptides: From Bench to Bedside
Jafari, A., Babajani, A., Sarrami‐Forooshani, R., Yazdani, M., & Rezaei–Tavirani, M. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.819563 · Cited by 99
Poff, A. M., Ward, N. P., Seyfried, T. N., Arnold, P., & D’Agostino, D. P. (2015) · PLoS ONE · doi:10.1371/journal.pone.0127407 · Cited by 98
Gene therapy to enhance angiogenesis in chronic wounds
Shaabani, E., Sharifiaghdam, M., Majidi, R. F., Smedt, S. C. D., Braeckmans, K., & Fraire, J. C. (2022) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2022.08.020 · Cited by 102
Modulating the tumor microenvironment to increase radiation responsiveness
Karar, J., & Maity, A. M. (2009) · Cancer Biology & Therapy · doi:10.4161/cbt.8.21.9988 · Cited by 99
Zeng, L., Morinibu, A., Kobayashi, M., Zhu, Y., Wang, X., Gotö, Y., Yeom, C. J., Zhao, T., Hirota, K., Shinomiya, K., et al. (2014) · Oncogene · doi:10.1038/onc.2014.411 · Cited by 96
The ketogenic diet for the treatment of malignant glioma
Woolf, E. C., & Scheck, A. C. (2014) · Journal of Lipid Research · doi:10.1194/jlr.r046797 · Cited by 96
Progress toward Overcoming Hypoxia-Induced Resistance to Solid Tumor Therapy
Reginato, M., & Karakashev, S. (2015) · Cancer Management and Research · doi:10.2147/cmar.s58285 · Cited by 95
Sato, M., Yao, V. J., Arap, W., & Pasqualini, R. (2010) · Advances in genetics · doi:10.1016/s0065-2660(10)69006-2 · Cited by 92
Hypoxia‑inducible factors in hepatocellular carcinoma (Review)
Guo, Y., Xiao, Z., Liu, Y., Gao, Y., Zhu, Q., Hu, L., Huang, D., & Xu, Q. (2019) · Oncology Reports · doi:10.3892/or.2019.7397 · Cited by 94
Nakashima, R., Gotö, Y., Koyasu, S., Kobayashi, M., Morinibu, A., Yoshimura, M., Hiraoka, M., Hammond, E. M., & Harada, H. (2017) · Scientific Reports · doi:10.1038/s41598-017-06605-1 · Cited by 92
Kannagi, R., Sakuma, K., Miyazaki, K., Lim, K., Yusa, A., Yin, J., & Izawa, M. (2009) · Cancer Science · doi:10.1111/j.1349-7006.2009.01455.x · Cited by 91
The human papillomavirus E7 oncoprotein as a regulator of transcription
Songock, W. K., Kim, S., & Bodily, J. M. (2016) · Virus Research · doi:10.1016/j.virusres.2016.10.017 · Cited by 97
Biswas, S., Troy, H., Leek, R., Chung, Y.-L., Li, J.-L., Raval, R. R., Turley, H., Gatter, K., Pezzella, F., Griffiths, J. R., et al. (2010) · Journal of Oncology · doi:10.1155/2010/757908 · Cited by 89
Drabovich, A. P., Pavlou, M. P., Dimitromanolakis, A., & Diamandis, E. P. (2012) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m111.015214 · Cited by 90
Targeting cancer-cell mitochondria and metabolism to improve radiotherapy response
McCann, E., O'Sullivan, J. N., & Marcone, S. (2020) · Translational Oncology · doi:10.1016/j.tranon.2020.100905 · Cited by 89
Redox-Based Escape Mechanism from Death: The Cancer Lesson
Pani, G., Giannoni, E., Galeotti, T., & Chiarugi, P. (2009) · Antioxidants and Redox Signaling · doi:10.1089/ars.2009.2739 · Cited by 92
Moroney, J. W., Fu, S., Moulder, S. L., Falchook, G. S., Helgason, T., Levenback, C., Hong, D. S., Naing, A., Wheler, J. J., & Kurzrock, R. (2012) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-12-1158 · Cited by 87
Privat‐Maldonado, A., Bengtson, C., Razzokov, J., Smits, E., & Bogaerts, A. (2019) · Cancers · doi:10.3390/cancers11121920 · Cited by 90
Redox‐ and Hypoxia‐Responsive MRI Contrast Agents
Do, Q. N., Ratnakar, J., Kovács, Z. Z., & Sherry, A. D. (2014) · ChemMedChem · doi:10.1002/cmdc.201402034 · Cited by 89
Kobayashi, M., Morinibu, A., Koyasu, S., Gotö, Y., Hiraoka, M., & Harada, H. (2017) · FEBS Journal · doi:10.1111/febs.14280 · Cited by 82
NFκB and HIF display synergistic behaviour during hypoxic inflammation
Brüning, U., Fitzpatrick, S. F., Frank, T. D., Birtwistle, M. R., Taylor, C. T., & Cheong, A. (2011) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-011-0876-2 · Cited by 85
Liu, W., Beck, B. H., Vaidya, K. S., Nash, K. T., Feeley, K. P., Ballinger, S. W., Pounds, K. M., Denning, W. L., Diers, A. R., Landar, A. L., et al. (2013) · Cancer Research · doi:10.1158/0008-5472.can-13-1183 · Cited by 85
Targeting mitochondria as a therapeutic target in cancer
Wenner, C. E. (2011) · Journal of Cellular Physiology · doi:10.1002/jcp.22788 · Cited by 82
Hypoxic metabolism in human hematopoietic stem cells
Kocabaş, F., Xie, L., Xie, J., Yu, Z., DeBerardinis, R. J., Kimura, W., Thet, S., Elshamy, A. F., Abouellail, H. A., Muralidhar, S. A., et al. (2015) · Cell & Bioscience · doi:10.1186/s13578-015-0020-3 · Cited by 85
miR-885-5p Negatively Regulates Warburg Effect by Silencing Hexokinase 2 in Liver Cancer
Xu, F., Yan, J., Gan, Y., Chang, Y., Wang, H., He, X., & Zhao, Q. (2019) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2019.09.002 · Cited by 78
Metabolism of Kidney Cancer: From the Lab to Clinical Practice
Sudarshan, S., Karam, J. A., Brugarolas, J., Thompson, R. H., Uzzo, R. G., Rini, B. I., Margulis, V., Patard, J., Escudier, B. J., & Linehan, W. M. (2012) · European Urology · doi:10.1016/j.eururo.2012.09.054 · Cited by 79
Sun, H., Zhu, A.-Y., Zhou, X., & Wang, F. (2017) · Oncotarget · doi:10.18632/oncotarget.16991 · Cited by 77
Targeting tumour angiogenesis with small molecule inhibitors of hypoxia inducible factor
Nordgren, I. K., & Tavassoli, A. (2011) · Chemical Society Reviews · doi:10.1039/c1cs15032d · Cited by 77
Koh, Y. W., Lee, S. J., & Park, S. Y. (2016) · Lung Cancer · doi:10.1016/j.lungcan.2016.12.003 · Cited by 76
Phenolic compound ellagic acid inhibits mitochondrial respiration and tumor growth in lung cancer
Duan, J., Li, Y., Gao, H., Yang, D., He, X., Fang, Y., & Zhou, G. (2020) · Food & Function · doi:10.1039/d0fo01177k · Cited by 75
Choe, M., Brusgard, J. L., Chumsri, S., Bhandary, L., Zhao, X. F., Lu, S., Goloubeva, O. G., Polster, B. M., Fiskum, G. M., Girnun, G. D., et al. (2015) · Journal of Cellular Biochemistry · doi:10.1002/jcb.25171 · Cited by 75
Keap1/Nrf2 pathway in the frontiers of cancer and non-cancer cell metabolism
Chartoumpekis, D. V., Wakabayashi, N., & Kensler, T. W. (2015) · Biochemical Society Transactions · doi:10.1042/bst20150049 · Cited by 78
Harguindey, S., Stanciu, D., Devesa, J., Alfarouk, K. O., Cardone, R. A., Orozco, J. D. P., Devesa, P., Rauch, C., Orive, G., Anitua, E., et al. (2017) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2017.02.003 · Cited by 75
Bao, L., Chen, S.-J., Conrad, K., Keefer, K. A., Abraham, T., Lee, J. P., Wang, J., Zhang, X.-Q., Hirschler‐Laszkiewicz, I., Wang, H., et al. (2016) · Journal of Biological Chemistry · doi:10.1074/jbc.m116.747147 · Cited by 76
Abebayehu, D., Spence, A. J., Qayum, A. A., Taruselli, M. T., McLeod, J. J. A., Caslin, H. L., Chumanevich, A. P., Kolawole, E. M., Paranjape, A. R., Baker, B., et al. (2016) · The Journal of Immunology · doi:10.4049/jimmunol.1600651 · Cited by 74
Zhang, Y., Fu, J. F., Zhang, Z.-J., Ge, C.-C., & Yi, Y. (2016) · PubMed Central · Cited by 70
Ameln, A. K., Muschter, A., Mamlouk, S., Kalucka, J. M., Prade, I., Franke, K., Rezaei, M., Poitz, D. M., Breier, G., & Wielockx, B. (2011) · Cancer Research · doi:10.1158/0008-5472.can-10-3838 · Cited by 71
Microenvironments and Cellular Characteristics in the Micro Tumor Cords of Malignant Solid Tumors
Yeom, C. J., Gotö, Y., Zhu, Y., Hiraoka, M., & Harada, H. (2012) · International Journal of Molecular Sciences · doi:10.3390/ijms131113949 · Cited by 70
Classification of cancers based on copy number variation landscapes
Zhang, N., Wang, M., Zhang, P., & Huang, T. (2016) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2016.06.003 · Cited by 66
HIF-1α Metabolic Pathways in Human Cancer
Elzakra, N., & Kim, Y. (2021) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-51652-9_17 · Cited by 72
Regulation of Aerobic Glycolysis by microRNAs in Cancer.
Singh, P. K., Mehla, K., Hollingsworth, M. A., & Johnson, K. R. (2011) · PubMed · Cited by 68
Chekulayev, V. A., Mado, K., Shevchuk, I. N., Koit, A., Kaldma, A., Klepinin, A., Timohhina, N., Tepp, K., Kandashvili, M., Ounpuu, L., et al. (2015) · Biochemistry and Biophysics Reports · doi:10.1016/j.bbrep.2015.08.020 · Cited by 71
Alteration in Cellular Signaling and Metabolic Reprogramming during Viral Infection
Pant, A., Dsouza, L., & Yang, Z. (2021) · mBio · doi:10.1128/mbio.00635-21 · Cited by 66
Metabolic phenotypes in triple-negative breast cancer
Kim, S., Kim, D. H., Jung, W.-H., & Koo, J. S. (2013) · Tumor Biology · doi:10.1007/s13277-013-0707-1 · Cited by 66
Zeng, M., Kikuchi, H., Pino, M. S., & Chung, D. C. (2010) · PLoS ONE · doi:10.1371/journal.pone.0010966 · Cited by 67
Nocentini, A., Trallori, E., Singh, S., Lomelino, C. L., Bartolucci, G., Mannelli, L. D. C., Ghelardini, C., McKENNA, R. V., Gratteri, P., & Supuran, C. T. (2018) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.8b01504 · Cited by 67
Zhu, G., Tang, Y., Li, L., Zheng, M. H., Jiang, J. D., Li, X., Chen, S.-X., & Liang, X. (2010) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-10-1408 · Cited by 66
Ultrasound beam steering of oxygen nanobubbles for enhanced bladder cancer therapy
Bhandari, P. N., Novikova, G., Goergen, C. J., & Irudayaraj, J. (2018) · Scientific Reports · doi:10.1038/s41598-018-20363-8 · Cited by 66
Mitochondrial uncoupling in cancer cells: Liabilities and opportunities
Baffy, G. (2017) · Biochimica et Biophysica Acta (BBA) - Bioenergetics · doi:10.1016/j.bbabio.2017.01.005 · Cited by 64
Hammami, A., Charpentier, T., Smans, M., & Stäger, S. (2015) · PLoS Pathogens · doi:10.1371/journal.ppat.1004938 · Cited by 65
Wang, P., Mai, C., Wei, Y.-L., Zhao, J.-J., Hu, Y.-M., Zeng, Z.-L., Yang, J., Lu, W.-H., Xu, R., & Huang, P. (2013) · Medical Oncology · doi:10.1007/s12032-013-0552-5 · Cited by 60
The Effects of GLUT1 on the Survival of Head and Neck Squamous Cell Carcinoma
Li, S., Yang, X., Wang, P., & Ran, X. (2013) · Cellular Physiology and Biochemistry · doi:10.1159/000354466 · Cited by 59
Mao, L., Chen, Q., Gong, K., Xu, X., Xie, Y., Zhang, W., Cao, H., Hu, T., Hong, X., & Zhan, Y.-Y. (2018) · Oncology Reports · doi:10.3892/or.2018.6318 · Cited by 60
DNA‐Binding Small Molecules as Inhibitors of Transcription Factors
Leung, C., Chan, D. S., Ma, V. P., & Ma, D. (2013) · Medicinal Research Reviews · doi:10.1002/med.21266 · Cited by 58
Hu, Q., Qin, Y., Ji, S., Shi, X., Dai, W., Fan, G., Li, S., Xu, W., Liu, W., Liu, M., et al. (2021) · Cancer Research · doi:10.1158/0008-5472.can-20-0414 · Cited by 59
Trans-Plasma Membrane Electron Transport in Mammals: Functional Significance in Health and Disease
Principe, D. D., Avigliano, L., Savini, I., & Catani, M. V. (2010) · Antioxidants and Redox Signaling · doi:10.1089/ars.2010.3247 · Cited by 58
Zhou, W., Wang, L., Gou, S., Wang, T., Zhang, M., Liu, T., & Wang, C. (2011) · Cancer Letters · doi:10.1016/j.canlet.2011.10.033 · Cited by 58
HSP90 Supports Tumor Growth and Angiogenesis through PRKD2 Protein Stabilization
Azoitei, N., Diepold, K., Brunner, C., ROUHI, A. M., Genze, F., Becher, A., Kestler, H. A., Lint, J. V., Chiosis, G., Koren, J., et al. (2014) · Cancer Research · doi:10.1158/0008-5472.can-14-1017 · Cited by 57
Availability, not respiratory capacity governs oxygen consumption of solid tumors
Vaupel, P. W., & Mayer, A. (2012) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2012.05.019 · Cited by 60
Spatiotemporal correlation between HIF ‐1α and bone regeneration
Tao, J., Miao, R., Liu, G., Qiu, X., Yang, B., Tan, X., Liu, L., Long, J., Tang, W. D., & Jing, W. (2022) · The FASEB Journal · doi:10.1096/fj.202200329rr · Cited by 58
Glycolysis links p53 function with NF‐κB signaling: Impact on cancer and aging process
Salminen, A., & Kaarniranta, K. (2010) · Journal of Cellular Physiology · doi:10.1002/jcp.22119 · Cited by 55
Jeon, Y. K., Yoo, D. R., Jang, Y. H., Jang, S. Y., & Nam, M. J. (2011) · Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics · doi:10.1016/j.bbapap.2011.05.015 · Cited by 56
Extended Ischemia Prevents HIF1α Degradation at Reoxygenation by Impairing Prolyl-hydroxylation
Serra‐Pérez, A., Planas, A. M., Núñez-O’Mara, A., Berra, E., García‐Villoria, J., Ribes, A., & Santalucı́a, T. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.101048 · Cited by 55
Boso, D., Rampazzo, E., Zanon, C., Bresolin, S., Maule, F., Porcù, E., Cani, A., Puppa, A. D., Trentin, L., Basso, G., et al. (2019) · Theranostics · doi:10.7150/thno.35882 · Cited by 56
Wang, X., & Schneider, A. (2010) · Carcinogenesis · doi:10.1093/carcin/bgq078 · Cited by 56
HPV, tumour metabolism and novel target identification in head and neck squamous cell carcinoma
Fleming, J. C., Woo, J., Moutasim, K. A., Mellone, M., Frampton, S. J., Mead, A., Ahmed, W., Wood, O., Robinson, H., Ward, M. J., et al. (2019) · British Journal of Cancer · doi:10.1038/s41416-018-0364-7 · Cited by 54
do Amaral, R. F., Geraldo, L. H., Einicker‐Lamas, M., Spohr, T. C. L. D. S. E., Mendes, F. A., & Lima, F. R. S. (2020) · Journal of Neurochemistry · doi:10.1111/jnc.15097 · Cited by 52
Hu, Z., Brooks, S. A., Dormoy, V., Hsu, C.-W., Hsu, H.-Y., Lin, L., Massfelder, T., Rathmell, W. K., Xia, M., Al‐Mulla, F., et al. (2015) · Carcinogenesis · doi:10.1093/carcin/bgv036 · Cited by 51
Sato, J., Kitagawa, Y., Yamazaki, Y., Hata, H., Okamoto, S., Shiga, T., Shindoh, M., Kuge, Y., & Tamaki, N. (2013) · Journal of Nuclear Medicine · doi:10.2967/jnumed.112.114355 · Cited by 52
Eisenreich, W., Rudel, T., Heesemann, J., & Goebel, W. (2017) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2017.00316 · Cited by 53
Hypoxia-Inducible PIM Kinase Expression Promotes Resistance to Antiangiogenic Agents
Casillas, A. L., Toth, R. K., Sainz, A. G., Singh, N., Desai, A. A., Kraft, A. S., & Warfel, N. A. (2017) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-17-1318 · Cited by 51
Exploring metabolic pathways that contribute to the stem cell phenotype
Vacanti, N. M., & Metallo, C. M. (2012) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2012.08.007 · Cited by 51
Redox balance and autophagy regulation in cancer progression and their therapeutic perspective
Khan, S. U., Fatima, K., Aisha, S., Hamza, B., & Malik, F. A. (2022) · Medical Oncology · doi:10.1007/s12032-022-01871-0 · Cited by 50
Park, S., Kim, J., Son, T. G., Yi, J. M., Kim, N. D., Yang, K., & Heo, K. (2013) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2013.03.091 · Cited by 49
Gottschald, O. R., Malec, V., Krasteva‐Christ, G., Hasan, D., Kamlah, F., Herold, S., Rose, F., Seeger, W., & Hänze, J. (2010) · Journal of Molecular Cell Biology · doi:10.1093/jmcb/mjq032 · Cited by 52
Angiogenic signaling aberrantly induced by tumor hypoxia
Takenaga, K. (2010) · Frontiers in bioscience · doi:10.2741/3674 · Cited by 47
Cerezo-Magaña, M., Christianson, H. C., Kuppevelt, T. H. V., Forsberg‐Nilsson, K., & Belting, M. (2020) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-20-0560 · Cited by 47
Targeting Hypoxia in the Leukemia Microenvironment
Benito, J., Zeng, Z., Konopleva, M. Y., & Wilson, W. R. (2013) · International Journal of Hematologic Oncology · doi:10.2217/ijh.13.32 · Cited by 47
Targeting oxidative stress, a crucial challenge in renal transplantation outcome
Carcy, R., Cougnon, M., Poët, M., Durandy, M., Sicard, A., Counillon, L., Blondeau, N., Hauet, T., Tauc, M., & Pisani, D. F. (2021) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2021.04.023 · Cited by 50
The influence of pH and hypoxia on tumor metastasis
Abaza, M., & Luqmani, Y. A. (2013) · Expert Review of Anticancer Therapy · doi:10.1586/14737140.2013.843455 · Cited by 46
Macrophage Motility in Wound Healing Is Regulated by HIF-1α via S1P Signaling
Hutami, I. R., Izawa, T., Khurel‐Ochir, T., Sakamaki, T., Iwasa, A., & Tanaka, E. I. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22168992 · Cited by 49
Leiomyoma Cutis: A Focused Review on Presentation, Management, and Association with Malignancy
Malik, K., Patel, P. S., Chen, J., & Khachemoune, A. (2015) · American Journal of Clinical Dermatology · doi:10.1007/s40257-015-0112-1 · Cited by 45
Diverging prognostic impacts of hypoxic markers according to NSCLC histology
Andersen, S., Eilertsen, M., Dønnem, T., Al-Shibli, K. I., Al‐Saad, S., Busund, L., & Bremnes, R. M. (2010) · Lung Cancer · doi:10.1016/j.lungcan.2010.10.006 · Cited by 45
Bondanese, V. P., Lamboux, A., Simon, M., Lafont, J. E., Albalat, E., Pichat, S., Vanacker, J.-M., Télouk, P., Balter, V., Oger, P., et al. (2016) · Metallomics · doi:10.1039/c6mt00102e · Cited by 47
Metabolic reprogramming of the tumor microenvironment by p62 and its partners
Reina‐Campos, M., Shelton, P. M., Díaz-Meco, M. T., & Moscat, J. (2018) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2018.04.010 · Cited by 46
Guérin, E., Raffelsberger, W., Pencreach, E., Maier, A., Neuville, A., Schneider, A., Bachellier, P., Rohr, S., Petitprez, A., Poch, O., et al. (2012) · Molecular Medicine · doi:10.2119/molmed.2011.00120 · Cited by 44
Interplay Between Metabolism and Oncogenic Process: Role of microRNAs
Arora, A., Singh, S. P., Bhatt, A. N., Pandey, S., Sandhir, R., & Dwarakanath, B. S. R. (2015) · Translational Oncogenomics · doi:10.4137/tog.s29652 · Cited by 43
Kasinskas, R. W., Venkatasubramanian, R., & Forbes, N. S. (2014) · Integrative Biology · doi:10.1039/c4ib00001c · Cited by 44
Regulation of lactate dehydrogenase in response to WSSV infection in the shrimp Litopenaeus vannamei
Hernandez‐Palomares, M. L. E., Godoy-Lugo, J. A., Gómez‐Jiménez, S., Gámez-Alejo, L. A., Ortiz, R. M., Muñóz-Valle, J. F., Peregrino-Uriarte, A. B., Yepiz-Plascencia, G. M., Rosas‐Rodríguez, J. A., & Soñanez‐Organis, J. G. (2018) · Fish & Shellfish Immunology · doi:10.1016/j.fsi.2018.01.011 · Cited by 44
Qin, X., Lin, L., Cao, L., Zhang, X., Song, X., Hao, J., Zhang, Y., Wei, R., Huang, X., Lu, J., et al. (2017) · Scientific Reports · doi:10.1038/srep45305 · Cited by 42
Current Understanding of the HIF-1-Dependent Metabolism in Oral Squamous Cell Carcinoma
Eckert, A. W., Kappler, M., Große, I., Wickenhauser, C., & Seliger, B. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21176083 · Cited by 42
Shaabani, E., Sharifiaghdam, M., Lammens, J., Keersmaecker, H. D., Vervaet, C., Beer, T. D., Motevaseli, E., Ghahremani, M. H., Mansouri, P., Smedt, S. C. D., et al. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22179216 · Cited by 43
Dai, Q., Yin, Q., Wei, L., Zhou, Y., Qiao, C., Guo, Y., Wang, X., Ma, S., & Lu, N. (2015) · Molecular Carcinogenesis · doi:10.1002/mc.22369 · Cited by 43
Noncoding RNAs in Regulation of Cancer Metabolic Reprogramming
Yang, D., Sun, L., Li, Z., & Gao, P. (2016) · Advances in experimental medicine and biology · doi:10.1007/978-981-10-1498-7_7 · Cited by 42
The VHL/HIF Axis in the Development and Treatment of Pheochromocytoma/Paraganglioma
Song, P., Zhang, J., Tan, X., Huang, Y., Xu, J., Silk, N., Zhang, D., Liu, Q., & Jiang, J. (2020) · Frontiers in Endocrinology · doi:10.3389/fendo.2020.586857 · Cited by 42
Stra13 and Sharp-1, the Non-Grouchy Regulators of Development and Disease
Ow, J. R., Tan, Y. H., Jin, Y., Bahirvani, A. G., & Taneja, R. (2014) · Current topics in developmental biology/Current Topics in Developmental Biology · doi:10.1016/b978-0-12-405943-6.00009-9 · Cited by 39
Metadata
- Authors
- Semenza, G. L.
- Affiliations
- Johns Hopkins University (US)
- Corresponding author
- Semenza, Gregg L.
- ORCID
- Semenza, Gregg L.
- Venue
- Seminars in Cancer Biology
- Publisher
- Elsevier BV
- Published
- 2009-02
- Volume
- 19
- Issue
- 1
- Pages
- 12-16
- ISSN
- 1044-579X (ISSN-L)
- OpenAlex
- W2102416115
- Cited by
- 469
- References
- 67
- Citations by year
- 2026: 14 · 2025: 11 · 2024: 15 · 2023: 19 · 2022: 14 · 2021: 28 · 2020: 21 · 2019: 21 · 2018: 22 · 2017: 29 · 2016: 36 · 2015: 32 · 2014: 33 · 2013: 35 · 2012: 35
- FWCI
- 2.46
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Seminars in Cancer Biology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Hypoxia, and Metabolism
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Angiogenesis and VEGF in Cancer
- Keywords
- HIF-1, cancer metabolism, tumor hypoxia, VHL gene, glucose transport, glycolysis, mitochondrial metabolism, reactive oxygen species, HIF-1 target genes, metabolic reprogramming, cancer therapy
- MeSH terms
- Animals, Glycolysis, Humans, Neoplasms, Cell Hypoxia, Gene Expression Regulation, Neoplastic, Reactive Oxygen Species, Hypoxia-Inducible Factor 1, Von Hippel-Lindau Tumor Suppressor Protein, Metabolic Networks and Pathways
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review